JPRN-UMIN000017732已完成4 期
Comparison of clopidogrel and prasugrel as prophylaxis for In-stent protrusion evaluated by optical coherence tomography in patients with ST-segment elevation myocardial infarction - INSPECT-MI
Yokohama city university medical center Cardiovascular center0 个研究点目标入组 50 人开始时间: 2015年5月29日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(1)Use of oral anticoagulants, ticlodipine, cilostazol and clopidogrel (2)Cardiopulmonary arrest or prolonged CPR (3)Cardiogenic shock (4)STEMI caused by coronary artery bypass graft disease or in-stent restenosis (5)Unsuitable for stent implantation (6)Severe chronic renal failure with serum creatinine >2mg/dL (7)Left main trunk disease (8) Serum hemoglobin level < 9g/dL or >18g/dL Platelet count < 50,000 /mm3 or > 500,000 /mm3 (9) Hematologic or malignant disorder with the life expectancy < 1 year (10)Major bleeding events within 7 days before enrollment (11) Severe liver dysfunction (hepatic cirrhosis or portal hypertension) (12)Drug allergy to aspirin, clopidogrel or prasugrel (13)Women of pregnant, childbearing potential or lactation (14)Participating in the other trial (phase 1-3) (15)Patients who are not allowed to participate in the trial by judgement of the treating physician
研究者
相似试验
进行中（未招募）
不适用
Effectiveness of Prasugrel versus Clopidogrel in Subjects with High Platelet Reactivity on Clopidogrel Following Elective Percutaneous Coronary Intervention with Implantation of Drug-Eluting Stent - TACWReduction of composite cardio-vascular end-point in patients who have successfully undergone elective percutaneous coronary intervention with placement of at least one drug-eluting stent.EUCTR2008-004997-41-DEEli Lilly and Company3,250
进行中（未招募）
1 期
Prasugrel in comparison to Clopidogrel for Inhibition of Platelet Activation and Aggregation (PRINCIPLE) - TIMI 44 - Principle -TIMI 44EUCTR2006-000813-39-FREli Lilly and Company180
进行中（未招募）
不适用
Prasugrel in comparison to Clopidogrel for Inhibition of Platelet Activation and Aggregation (PRINCIPLE) - TIMI 44 - Principle -TIMI 44subjects undergoing elective cardiac catheterization with planned percutaneous coronary intervention (PCI) with coronary stenting.EUCTR2006-000813-39-DEEli Lilly and Company180
进行中（未招募）
不适用
The effect of clopidogrel and prasugrel with and without acetylsalicylic acid (ASA) on hemostatic system activation at the site of plug formation in vivo in macoronary artery disease and acute coronary syndromeEUCTR2010-019643-19-ATMedizinische Universität Wien, Univ.Klinik f.Innere Medizin I, Abt.f.Hämatologie u.Hämostaseologie
进行中（未招募）
不适用
A Comparison of Prasugrel and Clopidogrel in Acute Coronary Syndrome (ACS) Subjects with Unstable Angina/Non-ST-Elevation Myocardial Infarction (UA/NSTEMI) Who are Medically Managed - The TRILOGY ACS Study - Trilogy ACSTreatment of Acute Coronary Syndrome in medically managed subjects enrolled within 10 days of the unstable angina/non-ST-segment elevation myocardial infarction (UA/NSTEMI) index event.MedDRA version: 9.1Level: LLTClassification code 10051592Term: Acute coronary syndromeEUCTR2007-005210-39-MTEli Lilly and Company11,200